Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:46 pm Sale | 2024-09-30 | 13G | CELCUITY INC CELC | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | -2,476,980 (Position Closed) | Filing History |
| 2024-11-14 5:45 pm Purchase | 2024-09-30 | 13G | ASTRIA THERAPEUTICS INC ATXS | Venrock Healthcare Capital Partners III, L.P. | 3,458,645 6.100% | 232,839 (+7.22%) | Filing History |
| 2024-08-19 4:15 pm Purchase | 2024-08-08 | 13G | TENAX THERAPEUTICS INC PAR TENX | Venrock Healthcare Capital Partners III, L.P. | 355,224 9.990% | 355,224 (New Position) | Filing History |
| 2024-08-01 4:18 pm Purchase | 2024-07-22 | 13G | ARTIVA BIOTHERAPEUTICS INC ARTV | Venrock Healthcare Capital Partners III, L.P. | 1,609,569 6.900% | 1,609,569 (New Position) | Filing History |
| 2024-07-25 8:48 pm Purchase | 2024-07-15 | 13G | CASI PHARMACEUTICALS HLDGS INC CASIF | Venrock Healthcare Capital Partners III, L.P. | 1,507,040 9.990% | 1,507,040 (New Position) | Filing History |
| 2024-06-24 4:15 pm Purchase | 2024-06-13 | 13G | PERCEPTIVE CAP SOLUTIONS CORP PCSC | Venrock Healthcare Capital Partners III, L.P. | 750,000 8.400% | 750,000 (New Position) | Filing History |
| 2024-05-31 4:18 pm Purchase | 2024-05-21 | 13G | ERASCA INC ERAS | Venrock Healthcare Capital Partners III, L.P. | 16,216,216 6.500% | 16,216,216 (New Position) | Filing History |
| 2024-05-02 4:16 pm Purchase | 2024-04-22 | 13G | ZURA BIO LTD ZURA | Venrock Healthcare Capital Partners III, L.P. | 6,399,619 9.990% | 6,399,619 (New Position) | Filing History |
| 2024-04-29 7:28 pm Purchase | 2024-04-17 | 13G | ARCA BIOPHARMA INC PAR $.0 ABIO | Venrock Healthcare Capital Partners III, L.P. | 62,889 5.200% | 62,889 (New Position) | Filing History |
| 2024-04-01 6:21 pm Purchase | 2024-03-22 | 13G | AQUESTIVE THERAPEUTICS INC AQST | Venrock Healthcare Capital Partners III, L.P. | 5,555,555 6.500% | 5,555,555 (New Position) | Filing History |
| 2024-03-04 4:16 pm Purchase | 2024-02-21 | 13G | CENTURY THERAPEUTICS INC IPSC | Venrock Healthcare Capital Partners III, L.P. | 3,405,133 5.400% | 3,405,133 (New Position) | Filing History |
| 2024-02-26 4:15 pm Purchase | 2024-02-16 | 13G | ENGENE HLDGS INC ENGN | Venrock Healthcare Capital Partners III, L.P. | 2,565,841 5.900% | 2,565,841 (New Position) | Filing History |
| 2024-02-14 9:20 pm Purchase | 2023-12-31 | 13G | APPLIED THERAPEUTICS INC APLT | Venrock Healthcare Capital Partners III, L.P. | 7,877,817 9.990% | 2,080,232 (+35.88%) | Filing History |
| 2024-02-14 9:13 pm Sale | 2023-12-31 | 13G | AVALO THERAPEUTICS INC PAR AVTX | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | -5,635 (Position Closed) | Filing History |
| 2024-02-14 8:56 pm Purchase | 2023-12-31 | 13G | MERSANA THERAPEUTICS INC MRSN | Venrock Healthcare Capital Partners III, L.P. | 453,120 9.400% | 66,000 (+17.05%) | Filing History |
| 2024-02-14 8:56 pm Sale | 2023-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Venrock Healthcare Capital Partners III, L.P. | 925,048 2.800% | -1,283,764 (-58.12%) | Filing History |
| 2024-02-14 8:53 pm Purchase | 2023-12-31 | 13G | CABALETTA BIO INC CABA | Venrock Healthcare Capital Partners III, L.P. | 2,563,952 6.400% | 668,667 (+35.28%) | Filing History |
| 2024-02-14 8:53 pm Purchase | 2023-12-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Venrock Healthcare Capital Partners III, L.P. | 2,954,902 7.200% | 740,760 (+33.46%) | Filing History |
| 2024-02-14 8:52 pm Purchase | 2023-12-31 | 13G | KALVISTA PHARMACEUTICALS INC C KALV | Venrock Healthcare Capital Partners III, L.P. | 4,824,731 14.000% | 1,251,017 (+35.01%) | Filing History |
| 2024-02-14 8:51 pm Purchase | 2023-12-31 | 13G | 4D MOLECULAR THERAPEUTICS INC. FDMT | Venrock Healthcare Capital Partners III, L.P. | 4,400,000 8.900% | 1,512,483 (+52.38%) | Filing History |